Multicenter real-world data of patients harboring rare mutations other than EGFR or ALK in advanced or metastatic non-small cell lung cancer.
Su Yeon LeeYoung-Chul KimKye Young LeeSung-Yong LeeShin Yup LeeMin Ki LeeJeong Eun LeeSeung Hun JangTae-Won JangChang-Min ChoiPublished in: Thoracic cancer (2021)
First-line platinum-based chemotherapy showed durable benefit in patients with advanced or metastatic nonsquamous NSCLC harboring rare genetic mutation other than EGFR or ALK.
Keyphrases
- small cell lung cancer
- advanced non small cell lung cancer
- epidermal growth factor receptor
- end stage renal disease
- squamous cell carcinoma
- tyrosine kinase
- ejection fraction
- peritoneal dialysis
- prognostic factors
- electronic health record
- genome wide
- clinical trial
- patient reported outcomes
- gene expression
- cross sectional
- copy number
- data analysis